Gilligan, who has worked for both an insurer and a health system, accepted the role as CEO during a period defined by the blockbuster popularity of GLP-1 weight-loss drugs, soaring health care costs, and the lingering consequences of the COVID pandemic
Both GIPR co-agonism (as in tirzepatide) and GIPR antagonism (as in MariTide, a bispecific hybrid molecule comprising two GLP-1R agonist peptides conjugated to a monoclonal anti-GIPR antagonistic antibody) are effective in treating people living with obesity 2,3,22
The pills contain salcaprozate sodium, which helps protect the active ingredients from stomach acids and allows absorption across the stomach lining, Jaisinghani explains
Design and baseline characteristics of the STRIDE trial: evaluating semaglutide in people with symptomatic peripheral artery disease and type 2 diabetes
Experience expert-led, personalized care in a relaxing, elegant setting
The gut adaptation to GLP-1 medications sometimes manifests as loose stools or increased bowel frequency